<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>IP Patent News &#187; International</title>
	<atom:link href="http://www.ip-patent-news.com/tag/international/feed" rel="self" type="application/rss+xml" />
	<link>http://www.ip-patent-news.com</link>
	<description>24/7 Technology,Internet,Bio Patent and Intellectual Property News &#38; Information Service</description>
	<lastBuildDate>Mon, 06 Sep 2010 04:57:55 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Nvidia Licenses Rambus Memory Patents</title>
		<link>http://news.yahoo.com/s/pcworld/20100813/tc_pcworld/nvidialicensesrambusmemorypatents_1</link>
		<comments>http://www.ip-patent-news.com/nvidia-licenses-rambus-memory-patents#comments</comments>
		<pubDate>Fri, 13 Aug 2010 16:30:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Nvidia]]></category>
		<category><![CDATA[Trade]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/nvidia-licenses-rambus-memory-patents</guid>
		<description><![CDATA[[Story ID: 3393] Nvidia has signed an agreement to license Rambus patents on memory controllers following a ruling against Nvidia at the U.S. International Trade Commission, the two companies announced.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/nvidia-licenses-rambus-memory-patents">3393</a>]</small>
<p>Nvidia has signed an agreement to license Rambus patents on memory controllers following a ruling against Nvidia at the U.S. International Trade Commission, the two companies announced.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/nvidia-licenses-rambus-memory-patents/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>An overview of IntraHealth-UNC Summer Fellows Program</title>
		<link>http://www.news-medical.net/news/20100802/An-overview-of-IntraHealth-UNC-Summer-Fellows-Program.aspx</link>
		<comments>http://www.ip-patent-news.com/an-overview-of-intrahealth-unc-summer-fellows-program#comments</comments>
		<pubDate>Mon, 02 Aug 2010 05:56:51 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Global]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/an-overview-of-intrahealth-unc-summer-fellows-program</guid>
		<description><![CDATA[[Story ID: 3354] Four master&#8217;s students and one doctoral candidate from the UNC Gillings School of Global Public Health shared their global health research and insights at the culmination of a 10-week joint fellowship with IntraHealth International this Wednesday during a poster exhibition and discussion with faculty and staff.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/an-overview-of-intrahealth-unc-summer-fellows-program">3354</a>]</small>
<p>Four master&#8217;s students and one doctoral candidate from the UNC Gillings School of Global Public Health shared their global health research and insights at the culmination of a 10-week joint fellowship with IntraHealth International this Wednesday during a poster exhibition and discussion with faculty and staff.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/an-overview-of-intrahealth-unc-summer-fellows-program/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Richtek claims victory in patent lawsuit against uPI Semiconductor</title>
		<link>http://www.digitimes.com/news/a20100723PB200.html</link>
		<comments>http://www.ip-patent-news.com/richtek-claims-victory-in-patent-lawsuit-against-upi-semiconductor#comments</comments>
		<pubDate>Fri, 23 Jul 2010 04:41:59 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Consent]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Order]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/richtek-claims-victory-in-patent-lawsuit-against-upi-semiconductor</guid>
		<description><![CDATA[[Story ID: 3138] Analog IC design house Richtek Technology claims that it has won a patent lawsuit against rival uPI Semiconductor which recently applied for a consent order from the US International Trade Commission (ITC) aiming to settle the case.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/richtek-claims-victory-in-patent-lawsuit-against-upi-semiconductor">3138</a>]</small>
<p>Analog IC design house Richtek Technology claims that it has won a patent lawsuit against rival uPI Semiconductor which recently applied for a consent order from the US International Trade Commission (ITC) aiming to settle the case.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/richtek-claims-victory-in-patent-lawsuit-against-upi-semiconductor/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New therapy to reduce side effects of neurobastoma in children</title>
		<link>http://www.news-medical.net/news/20100721/New-therapy-to-reduce-side-effects-of-neurobastoma-in-children.aspx</link>
		<comments>http://www.ip-patent-news.com/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children#comments</comments>
		<pubDate>Wed, 21 Jul 2010 04:48:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Published]]></category>
		<category><![CDATA[Study]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children</guid>
		<description><![CDATA[[Story ID: 3075] Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children">3075</a>]</small>
<p>Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New microbicide gel reduces womans risk of being infected with HIV, genital herpes</title>
		<link>http://www.news-medical.net/news/20100720/New-microbicide-gel-reduces-womans-risk-of-being-infected-with-HIV-genital-herpes.aspx</link>
		<comments>http://www.ip-patent-news.com/new-microbicide-gel-reduces-womans-risk-of-being-infected-with-hiv-genital-herpes#comments</comments>
		<pubDate>Tue, 20 Jul 2010 05:59:45 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Advocates]]></category>
		<category><![CDATA[Hiv]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/new-microbicide-gel-reduces-womans-risk-of-being-infected-with-hiv-genital-herpes</guid>
		<description><![CDATA[[Story ID: 3049] Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/new-microbicide-gel-reduces-womans-risk-of-being-infected-with-hiv-genital-herpes">3049</a>]</small>
<p>Today at the XVIII International AIDS Conference in Vienna, Austria, members of the International Rectal Microbicide Advocates (IRMA) and thousands of other HIV advocates and scientists cheered a long-awaited, much anticipated success in the quest for new HIV prevention technologies. Researchers announced that a vaginal gel has been shown to significantly reduce a woman&#8217;s risk of being infected with HIV and genital herpes</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/new-microbicide-gel-reduces-womans-risk-of-being-infected-with-hiv-genital-herpes/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ahead of International AIDS Conference, health experts call for scientifically-based drug policies</title>
		<link>http://www.news-medical.net/news/20100629/Ahead-of-International-AIDS-Conference-health-experts-call-for-scientifically-based-drug-policies.aspx</link>
		<comments>http://www.ip-patent-news.com/ahead-of-international-aids-conference-health-experts-call-for-scientifically-based-drug-policies#comments</comments>
		<pubDate>Tue, 29 Jun 2010 04:57:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Evidence]]></category>
		<category><![CDATA[Increase]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/ahead-of-international-aids-conference-health-experts-call-for-scientifically-based-drug-policies</guid>
		<description><![CDATA[[Story ID: 2540] Ahead of the International AIDS Conference, scheduled to kick off July 18, health experts on Monday called for a rethinking of international drug policies to incorporate greater scientific evidence and increase access to HIV prevention, treatment and care, the Associated Press reports (6/28).]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/ahead-of-international-aids-conference-health-experts-call-for-scientifically-based-drug-policies">2540</a>]</small>
<p>Ahead of the International AIDS Conference, scheduled to kick off July 18, health experts on Monday called for a rethinking of international drug policies to incorporate greater scientific evidence and increase access to HIV prevention, treatment and care, the Associated Press reports (6/28).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/ahead-of-international-aids-conference-health-experts-call-for-scientifically-based-drug-policies/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Inova Labs completes $10 million Series A Preferred Stock financing</title>
		<link>http://www.news-medical.net/news/20100520/Inova-Labs-completes-2410-million-Series-A-Preferred-Stock-financing.aspx</link>
		<comments>http://www.ip-patent-news.com/inova-labs-completes-10-million-series-a-preferred-stock-financing#comments</comments>
		<pubDate>Thu, 20 May 2010 04:58:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Inova]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>
		<category><![CDATA[Placement]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/inova-labs-completes-10-million-series-a-preferred-stock-financing</guid>
		<description><![CDATA[[Story ID: 1912] Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be [...]]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/inova-labs-completes-10-million-series-a-preferred-stock-financing">1912</a>]</small>
<p>Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/inova-labs-completes-10-million-series-a-preferred-stock-financing/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ICTP to participate in QWeCl project to help fight malaria and other vector-borne illnesses</title>
		<link>http://www.news-medical.net/news/20100424/ICTP-to-participate-in-QWeCl-project-to-help-fight-malaria-and-other-vector-borne-illnesses.aspx</link>
		<comments>http://www.ip-patent-news.com/ictp-to-participate-in-qwecl-project-to-help-fight-malaria-and-other-vector-borne-illnesses#comments</comments>
		<pubDate>Sat, 24 Apr 2010 04:34:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Deploying]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/ictp-to-participate-in-qwecl-project-to-help-fight-malaria-and-other-vector-borne-illnesses</guid>
		<description><![CDATA[[Story ID: 1482] The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/ictp-to-participate-in-qwecl-project-to-help-fight-malaria-and-other-vector-borne-illnesses">1482</a>]</small>
<p>The Abdus Salam International Centre for Theoretical Physics is taking part in a newly-launched, major international, European Union-funded project to help fight malaria and other vector-borne illnesses by developing and deploying an early warning system for disease outbreaks in Africa.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/ictp-to-participate-in-qwecl-project-to-help-fight-malaria-and-other-vector-borne-illnesses/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MediaG3 Retains Acclaimed Patent Law Firm for the Authentication of Standing Patents (Marketwire)</title>
		<link>http://www.marketwire.com/mw/release.do?id=1136365&amp;sourceType=3</link>
		<comments>http://www.ip-patent-news.com/mediag3-retains-acclaimed-patent-law-firm-for-the-authentication-of-standing-patents-marketwire#comments</comments>
		<pubDate>Tue, 23 Mar 2010 15:55:52 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Companys]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Yahoo Technology Patents]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/mediag3-retains-acclaimed-patent-law-firm-for-the-authentication-of-standing-patents-marketwire</guid>
		<description><![CDATA[[Story ID: 962] BOISE, ID&#8211;(Marketwire &#8211; March 23, 2010) &#8211; MediaG3, Inc. ( PINKSHEETS : MDGC ), announces today that, through AXS International, the Company retained Stephen Vitola, IP Attorney, who has verified the company&#8217;s US and international patents, which encompass the company&#8217;s broadband wireless back haul and cellular tower technologies.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/mediag3-retains-acclaimed-patent-law-firm-for-the-authentication-of-standing-patents-marketwire">962</a>]</small>
<p>BOISE, ID&#8211;(Marketwire &#8211; March 23, 2010) &#8211; MediaG3, Inc. ( PINKSHEETS : MDGC ), announces today that, through AXS International, the Company retained Stephen Vitola, IP Attorney, who has verified the company&#8217;s US and international patents, which encompass the company&#8217;s broadband wireless back haul and cellular tower technologies.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/mediag3-retains-acclaimed-patent-law-firm-for-the-authentication-of-standing-patents-marketwire/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Despite improvements, aid delivery bottlenecks persist in Haiti</title>
		<link>http://www.news-medical.net/news/20100204/Despite-improvements-aid-delivery-bottlenecks-persist-in-Haiti.aspx</link>
		<comments>http://www.ip-patent-news.com/despite-improvements-aid-delivery-bottlenecks-persist-in-haiti#comments</comments>
		<pubDate>Thu, 04 Feb 2010 05:49:43 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Administrator]]></category>
		<category><![CDATA[Agency]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Medical Patent News]]></category>

		<guid isPermaLink="false">http://www.ip-patent-news.com/despite-improvements-aid-delivery-bottlenecks-persist-in-haiti</guid>
		<description><![CDATA[[Story ID: 198] Three weeks after a major earthquake struck Haiti, challenges in getting aid to those in need persist, the Washington Post reports. &#8220;Rajiv Shah, the administrator of the U.S. Agency for International Development, said the relief effort has escalated in recent days and will continue to do so.]]></description>
			<content:encoded><![CDATA[<small>[Story ID: <a href="http://www.ip-patent-news.com/despite-improvements-aid-delivery-bottlenecks-persist-in-haiti">198</a>]</small>
<p>Three weeks after a major earthquake struck Haiti, challenges in getting aid to those in need persist, the Washington Post reports. &#8220;Rajiv Shah, the administrator of the U.S. Agency for International Development, said the relief effort has escalated in recent days and will continue to do so.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.ip-patent-news.com/despite-improvements-aid-delivery-bottlenecks-persist-in-haiti/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
